about
Incidentally detection of non-palpable testicular nodules at scrotal ultrasound: what is new?The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography.Imaging of penile traumas--therapeutic implications.Ultrasonography of the pancreas. 3. Doppler imaging.High-resolution, three-dimensional, and contrast-enhanced ultrasonographic findings in diseases of the eye().Painful penile induration: imaging findings and management.Inflammatory activity in Crohn's disease: CE-US.The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology.The use of CEUS in the diagnosis of retinal/choroidal detachment and associated intraocular masses - preliminary investigation in patients with equivocal findings at conventional ultrasound.Children and adults varicocele: diagnostic issues and therapeutical strategies.Contrast-enhanced ultrasound (CEUS) in nephrology: Has the time come for its widespread use?Penile fracture: retrospective analysis of our case history with long-term assessment of the erectile and sexological outcome.Growing indications for CEUS: The kidney, testis, lymph nodes, thyroid, prostate, and small bowel.Grayscale and color Doppler features of testicular lymphomaThe application of ultrasound contrast agents in the characterization of renal tumors.Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US.Imaging of mesothelioma of tunica vaginalis testis.It's not always varicocele: A strange case of Zinner syndrome.Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.Role of US in acute scrotal pain.Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses.Color Doppler appearance of penile cavernosal-spongiosal communications in patients with high-flow priapism.Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results.Solid Renal Tumors Isoenhancing to Kidneys on Contrast-Enhanced Sonography: Differentiation From Pseudomasses.Sonography of Scrotal Wall Lesions and Correlation With Other Modalities.Multiparametric US for scrotal diseases.Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee.Ultrasound-guided core-needle biopsy of extra-ocular orbital lesions.Application of ultrasound contrast agents for the characterization of female urethral vascularization in healthy pre- and postmenopausal volunteers: preliminary report.Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound.Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.Differential diagnosis between splenic nodules and peritoneal metastases with contrast-enhanced ultrasound based on signal-intensity characteristics during the late phase.Magnetic resonance urography vs computed tomography urography in the evaluation of patients with haematuria.Preoperative vascular mapping with multislice CT of deep inferior epigastric artery perforators in planning breast reconstruction after mastectomy.Sexual function after highly selective embolization of cavernous artery in patients with high flow priapism: long-term followup.High-flow priapism: treatment and long-term follow-up.Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI.Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients.
P50
Q26822998-FF2B4225-348E-4E3F-ADFC-8F4B1CEA2C7DQ34211494-A8B7C28B-D34C-45FD-B439-B824BC113947Q35852165-3B60EDF4-AE5A-41F1-8D2C-554EEFBD1C33Q36042575-6B0CFD26-763F-47BA-9CC1-0844A9EBB0F4Q36245215-E944F0A2-D42B-480B-9857-53B38CF590C2Q36545815-53EACA35-5456-460B-987D-CEDE2FA09D15Q36555692-8160F3D2-3458-4420-8DD8-E397334F73E9Q37424618-127C3D4E-184D-4387-929D-58FC39C08E9EQ37750529-48D4E5FA-6CAC-438B-867E-C1E0990BAAF6Q37878398-74824826-87D0-40DD-8CBA-9B88E2B27A67Q38085584-E73130A5-2CB3-4B0C-9508-63074716E921Q38245234-BEA445B1-78E8-4B54-8935-3F45C7AE0139Q38263401-1ED59875-5C17-44BC-96C1-D240FA0A7C73Q38340220-08C80230-B264-46B9-B6AB-F7612474BE1FQ38503572-70081DAD-2E3E-4431-9647-92B458E1F7E8Q38503643-3939E60E-F022-4968-8A15-B0F312853EFCQ39691714-CD99AD7F-67A3-4CB4-8077-36E75BF70D8AQ39897771-A697B4BF-1BC2-4646-A6CD-7F22F9098C20Q40792821-0D8CD266-4B34-46B3-ADB5-76D47B43C190Q41840571-0DB22E0A-6FC9-4D67-87D5-9C84080E0B8BQ43886501-D07ABF55-D524-4B9C-AF5C-C1FFDD6606C5Q44012818-E9A23729-4BAA-46C8-BC3B-4F237E64454FQ46355186-2D641731-2AC9-4007-9942-7A20945609C1Q46528215-360F5B7A-5064-4080-B904-365635368F1BQ46851565-92D519FD-4F3C-4126-B0BF-2DB2978630CCQ48325767-220D7E79-674B-4343-873F-8808618DC534Q48362894-8A0E418E-9785-4402-ADB9-77D84251B8BAQ49826873-C1612509-C478-4436-BF1E-B22E239EC149Q50622906-475F08BA-8E35-4420-A031-3975277946DBQ51273041-1B7F5235-9B55-4D22-A781-6B57C848F74AQ51796276-A8EB7077-AE37-4B9B-B3B3-590AC4FC3F30Q52597645-9A72BA38-9518-4FC1-A409-76640243ED13Q52925720-F0899DFD-FC2C-460F-B03D-612E21B209EAQ53046246-C8BE46E3-6614-42F6-A144-141B358C5C45Q53104094-E72DD92E-812A-4B57-AAB8-142D9509969BQ53135860-F24B119A-674D-47C9-856D-F8E56A26FB12Q53287508-EE4F5C49-D2F0-4710-AB4B-9EB19B1E25C7Q53318635-08A7B796-002D-453A-B602-792946A82A8EQ53393569-9B3B2B19-8492-4425-94C7-95D65DF771DFQ53643492-9A90B213-FB19-49F2-A2D9-D00CF9E6DB99
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michele Bertolotto
@ast
Michele Bertolotto
@en
Michele Bertolotto
@es
Michele Bertolotto
@nl
Michele Bertolotto
@sl
type
label
Michele Bertolotto
@ast
Michele Bertolotto
@en
Michele Bertolotto
@es
Michele Bertolotto
@nl
Michele Bertolotto
@sl
prefLabel
Michele Bertolotto
@ast
Michele Bertolotto
@en
Michele Bertolotto
@es
Michele Bertolotto
@nl
Michele Bertolotto
@sl
P106
P1153
7006975109
P21
P31
P496
0000-0001-5583-350X